Advertisement
Singapore markets close in 4 hours 25 minutes
  • Straits Times Index

    3,283.23
    -9.90 (-0.30%)
     
  • Nikkei

    37,685.91
    -774.17 (-2.01%)
     
  • Hang Seng

    17,295.93
    +94.66 (+0.55%)
     
  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     
  • Bitcoin USD

    64,269.18
    -2,422.62 (-3.63%)
     
  • CMC Crypto 200

    1,385.65
    -38.45 (-2.70%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Gold

    2,325.20
    -13.20 (-0.56%)
     
  • Crude Oil

    82.88
    +0.07 (+0.08%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • FTSE Bursa Malaysia

    1,570.16
    -1.32 (-0.08%)
     
  • Jakarta Composite Index

    7,148.81
    -25.73 (-0.36%)
     
  • PSE Index

    6,580.26
    +7.51 (+0.11%)
     

How Puma Biotechnology Is Positioned Financially before Q2 2018

How Puma Biotechnology Is Positioned Financially before Q2 2018

Puma Biotechnology (PBYI) generated revenues of $66.5 million in the first quarter, including revenues of $36 million and $30.5 million from product sales and licenses, respectively.